APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-injectable GnRH Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-injectable GnRH Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017580328 December 2025184 pages

Choose your research edition.

Industry ResearchNon-injectable GnRH Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-injectable GnRH Drugs Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Non-injectable GnRH Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-injectable GnRH Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-injectable GnRH Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Non-injectable GnRH Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-injectable GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-injectable GnRH Drugs include Sanofi, Pfizer, Abbvie, Sumitomo Pharma, ObsEva, Neon Healthcare, JW Pharmaceutical, Fuji Pharma and ASKA Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-injectable GnRH Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-injectable GnRH Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-injectable GnRH Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-injectable GnRH Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-injectable GnRH Drugs Segment by Company

Sanofi

Pfizer

Abbvie

Sumitomo Pharma

ObsEva

Neon Healthcare

JW Pharmaceutical

Fuji Pharma

ASKA Pharmaceutical

Non-injectable GnRH Drugs Segment by Type

Tablets

Nasal Spray

Others

Non-injectable GnRH Drugs Segment by Application

Menorrhagia

Central Precocious Puberty

Uterine Fibroids

Endometriosis

Other

Non-injectable GnRH Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-injectable GnRH Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-injectable GnRH Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-injectable GnRH Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-injectable GnRH Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-injectable GnRH Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-injectable GnRH Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-injectable GnRH Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-injectable GnRH Drugs Industry Trends Table 2. Non-injectable GnRH Drugs Industry Drivers Table 3. Non-injectable GnRH Drugs Industry Opportunities and Challenges Table 4. Non-injectable GnRH Drugs Industry Restraints Table 5. Global Non-injectable GnRH Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-injectable GnRH Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-injectable GnRH Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non-injectable GnRH Drugs Sales Market Share by Manufacturers Table 9. Global Non-injectable GnRH Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non-injectable GnRH Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-injectable GnRH Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-injectable GnRH Drugs Manufacturers, Product Type & Application Table 13. Global Non-injectable GnRH Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-injectable GnRH Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Nasal Spray Table 18. Major Manufacturers of Others Table 19. Global Non-injectable GnRH Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Non-injectable GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Non-injectable GnRH Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Non-injectable GnRH Drugs Sales Market Share by Type (2021-2026) Table 23. Global Non-injectable GnRH Drugs Sales Market Share by Type (2027-2032) Table 24. Global Non-injectable GnRH Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Non-injectable GnRH Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Non-injectable GnRH Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Menorrhagia Table 30. Major Manufacturers of Central Precocious Puberty Table 31. Major Manufacturers of Uterine Fibroids Table 32. Major Manufacturers of Endometriosis Table 33. Major Manufacturers of Other Table 34. Global Non-injectable GnRH Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Non-injectable GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Non-injectable GnRH Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Non-injectable GnRH Drugs Sales Market Share by Application (2021-2026) Table 38. Global Non-injectable GnRH Drugs Sales Market Share by Application (2027-2032) Table 39. Global Non-injectable GnRH Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Non-injectable GnRH Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Non-injectable GnRH Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Non-injectable GnRH Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Non-injectable GnRH Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Non-injectable GnRH Drugs Sales Market Share by Region (2021-2026) Table 47. Global Non-injectable GnRH Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Non-injectable GnRH Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Non-injectable GnRH Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Non-injectable GnRH Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Non-injectable GnRH Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Non-injectable GnRH Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Non-injectable GnRH Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Non-injectable GnRH Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Non-injectable GnRH Drugs Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi Non-injectable GnRH Drugs Product Portfolio Table 70. Sanofi Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Non-injectable GnRH Drugs Product Portfolio Table 75. Pfizer Recent Development Table 76. Abbvie Company Information Table 77. Abbvie Business Overview Table 78. Abbvie Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Abbvie Non-injectable GnRH Drugs Product Portfolio Table 80. Abbvie Recent Development Table 81. Sumitomo Pharma Company Information Table 82. Sumitomo Pharma Business Overview Table 83. Sumitomo Pharma Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio Table 85. Sumitomo Pharma Recent Development Table 86. ObsEva Company Information Table 87. ObsEva Business Overview Table 88. ObsEva Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. ObsEva Non-injectable GnRH Drugs Product Portfolio Table 90. ObsEva Recent Development Table 91. Neon Healthcare Company Information Table 92. Neon Healthcare Business Overview Table 93. Neon Healthcare Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Neon Healthcare Non-injectable GnRH Drugs Product Portfolio Table 95. Neon Healthcare Recent Development Table 96. JW Pharmaceutical Company Information Table 97. JW Pharmaceutical Business Overview Table 98. JW Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio Table 100. JW Pharmaceutical Recent Development Table 101. Fuji Pharma Company Information Table 102. Fuji Pharma Business Overview Table 103. Fuji Pharma Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Fuji Pharma Non-injectable GnRH Drugs Product Portfolio Table 105. Fuji Pharma Recent Development Table 106. ASKA Pharmaceutical Company Information Table 107. ASKA Pharmaceutical Business Overview Table 108. ASKA Pharmaceutical Non-injectable GnRH Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio Table 110. ASKA Pharmaceutical Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Non-injectable GnRH Drugs Distributors List Table 114. Non-injectable GnRH Drugs Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Non-injectable GnRH Drugs Product Image Figure 2. Global Non-injectable GnRH Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-injectable GnRH Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-injectable GnRH Drugs Sales (2021-2032) & (K Units) Figure 5. Global Non-injectable GnRH Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-injectable GnRH Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Nasal Spray Image Figure 10. Others Image Figure 11. Global Non-injectable GnRH Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Non-injectable GnRH Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Non-injectable GnRH Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Non-injectable GnRH Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Non-injectable GnRH Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021-2032) Figure 17. Menorrhagia Image Figure 18. Central Precocious Puberty Image Figure 19. Uterine Fibroids Image Figure 20. Endometriosis Image Figure 21. Other Image Figure 22. Global Non-injectable GnRH Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Non-injectable GnRH Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Non-injectable GnRH Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Non-injectable GnRH Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Non-injectable GnRH Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Non-injectable GnRH Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Non-injectable GnRH Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Non-injectable GnRH Drugs Sales Market Share by Country (2021-2032) Figure 42. China Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Non-injectable GnRH Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Non-injectable GnRH Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Non-injectable GnRH Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Non-injectable GnRH Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Non-injectable GnRH Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Non-injectable GnRH Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Non-injectable GnRH Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Non-injectable GnRH Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Non-injectable GnRH Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Non-injectable GnRH Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Nasal Spray
  • Others
Applications
  • Menorrhagia
  • Central Precocious Puberty
  • Uterine Fibroids
  • Endometriosis
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • Abbvie
  • Sumitomo Pharma
  • ObsEva
  • Neon Healthcare
  • JW Pharmaceutical
  • Fuji Pharma
  • ASKA Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-injectable GnRH Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-injectable GnRH Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-injectable GnRH Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-injectable GnRH Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-injectable GnRH Drugs Market Dynamics
  1. 2.1 Non-injectable GnRH Drugs Industry Trends
  2. 2.2 Non-injectable GnRH Drugs Industry Drivers
  3. 2.3 Non-injectable GnRH Drugs Industry Opportunities and Challenges
  4. 2.4 Non-injectable GnRH Drugs Industry Restraints
3 Non-injectable GnRH Drugs Market by Manufacturers
  1. 3.1 Global Non-injectable GnRH Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-injectable GnRH Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-injectable GnRH Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-injectable GnRH Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-injectable GnRH Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-injectable GnRH Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Non-injectable GnRH Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-injectable GnRH Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-injectable GnRH Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-injectable GnRH Drugs Tier 1, Tier 2, and Tier 3
4 Non-injectable GnRH Drugs Market by Type
  1. 4.1 Non-injectable GnRH Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Nasal Spray
  4. 4.1.3 Others
  5. 4.2 Global Non-injectable GnRH Drugs Sales by Type
  6. 4.2.1 Global Non-injectable GnRH Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Non-injectable GnRH Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Non-injectable GnRH Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Non-injectable GnRH Drugs Revenue by Type
  10. 4.3.1 Global Non-injectable GnRH Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Non-injectable GnRH Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Non-injectable GnRH Drugs Revenue Market Share by Type (2021-2032)
5 Non-injectable GnRH Drugs Market by Application
  1. 5.1 Non-injectable GnRH Drugs Application Introduction
  2. 5.1.1 Menorrhagia
  3. 5.1.2 Central Precocious Puberty
  4. 5.1.3 Uterine Fibroids
  5. 5.1.4 Endometriosis
  6. 5.1.5 Other
  7. 5.2 Global Non-injectable GnRH Drugs Sales by Application
  8. 5.2.1 Global Non-injectable GnRH Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Non-injectable GnRH Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Non-injectable GnRH Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Non-injectable GnRH Drugs Revenue by Application
  12. 5.3.1 Global Non-injectable GnRH Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Non-injectable GnRH Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Non-injectable GnRH Drugs Revenue Market Share by Application (2021-2032)
6 Global Non-injectable GnRH Drugs Sales by Region
  1. 6.1 Global Non-injectable GnRH Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-injectable GnRH Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Non-injectable GnRH Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Non-injectable GnRH Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-injectable GnRH Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-injectable GnRH Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-injectable GnRH Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-injectable GnRH Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-injectable GnRH Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-injectable GnRH Drugs Revenue by Region
  1. 7.1 Global Non-injectable GnRH Drugs Revenue by Region
  2. 7.1.1 Global Non-injectable GnRH Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-injectable GnRH Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-injectable GnRH Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-injectable GnRH Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-injectable GnRH Drugs Revenue (2021-2032)
  8. 7.2.2 North America Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-injectable GnRH Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-injectable GnRH Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-injectable GnRH Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-injectable GnRH Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Non-injectable GnRH Drugs Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Non-injectable GnRH Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Abbvie
  14. 8.3.1 Abbvie Company Information
  15. 8.3.2 Abbvie Business Overview
  16. 8.3.3 Abbvie Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Abbvie Non-injectable GnRH Drugs Product Portfolio
  18. 8.3.5 Abbvie Recent Developments
  19. 8.4 Sumitomo Pharma
  20. 8.4.1 Sumitomo Pharma Company Information
  21. 8.4.2 Sumitomo Pharma Business Overview
  22. 8.4.3 Sumitomo Pharma Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sumitomo Pharma Non-injectable GnRH Drugs Product Portfolio
  24. 8.4.5 Sumitomo Pharma Recent Developments
  25. 8.5 ObsEva
  26. 8.5.1 ObsEva Company Information
  27. 8.5.2 ObsEva Business Overview
  28. 8.5.3 ObsEva Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ObsEva Non-injectable GnRH Drugs Product Portfolio
  30. 8.5.5 ObsEva Recent Developments
  31. 8.6 Neon Healthcare
  32. 8.6.1 Neon Healthcare Company Information
  33. 8.6.2 Neon Healthcare Business Overview
  34. 8.6.3 Neon Healthcare Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neon Healthcare Non-injectable GnRH Drugs Product Portfolio
  36. 8.6.5 Neon Healthcare Recent Developments
  37. 8.7 JW Pharmaceutical
  38. 8.7.1 JW Pharmaceutical Company Information
  39. 8.7.2 JW Pharmaceutical Business Overview
  40. 8.7.3 JW Pharmaceutical Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JW Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
  42. 8.7.5 JW Pharmaceutical Recent Developments
  43. 8.8 Fuji Pharma
  44. 8.8.1 Fuji Pharma Company Information
  45. 8.8.2 Fuji Pharma Business Overview
  46. 8.8.3 Fuji Pharma Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fuji Pharma Non-injectable GnRH Drugs Product Portfolio
  48. 8.8.5 Fuji Pharma Recent Developments
  49. 8.9 ASKA Pharmaceutical
  50. 8.9.1 ASKA Pharmaceutical Company Information
  51. 8.9.2 ASKA Pharmaceutical Business Overview
  52. 8.9.3 ASKA Pharmaceutical Non-injectable GnRH Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ASKA Pharmaceutical Non-injectable GnRH Drugs Product Portfolio
  54. 8.9.5 ASKA Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-injectable GnRH Drugs Value Chain Analysis
  2. 9.1.1 Non-injectable GnRH Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-injectable GnRH Drugs Production Mode & Process
  6. 9.2 Non-injectable GnRH Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-injectable GnRH Drugs Distributors
  9. 9.2.3 Non-injectable GnRH Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst